Sector · close of 4 Nov 2026
Healthcare Stocks
177 NSE-listed healthcare companies, largest first, with each one's stage, price and valuation after the close.
177
companies
66 (37%)
in a Stage 2 uptrend
+1.6%
3-month return, weighted by size
4 · 51 · 45
in Stage 1 · 3 · 4
Only the Stage 2 ones →Filter them in the screener →Sector rotation →
Industries in Health Care
| Industry | Companies | In Stage 2 | 3-month return |
|---|---|---|---|
| Pharmaceuticals | 121 | 53 | +1.8% |
| Hospitals & Diagnostic Centres | 32 | 7 | -6.9% |
| Health Care Equipment & Supplies | 11 | 0 | -7.5% |
| Biotechnology | 9 | 4 | +1.9% |
| Labs & Life Sciences Services | 6 | 2 | +18.6% |
The 100 largest healthcare stocks
| Stock | Industry | Stage | Close | Day | 3 months | From high | RS | P/E | Yield | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMASun Pharmaceutical Industries | Pharmaceuticals | Stage 3, wk 5 | ₹1,773.40 | +0.2% | -9.7% | -11.4% | 72 | 39.1 | 0.90% | ₹4.25L Cr |
| DIVISLABDivi's Laboratories | Labs & Life Sciences Services | Stage 2, wk 24 | ₹10,037.50 | -0.3% | +19.8% | -0.3% | 91 | 91.3 | 0.30% | ₹2.66L Cr |
| TORNTPHARMTorrent Pharmaceuticals | Pharmaceuticals | Stage 3, wk 4 | ₹4,738.50 | +1.9% | -5.8% | -7.5% | 85 | 78.4 | 0.82% | ₹1.80L Cr |
| LAURUSLABSLaurus Labs | Pharmaceuticals | Stage 2, wk 28 | ₹2,323.80 | 0.0% | +25.6% | -3.4% | 97 | 93.0 | 0.05% | ₹1.26L Cr |
| APOLLOHOSPApollo Hospitals Enterprise | Hospitals & Diagnostic Centres | Stage 3, wk 5 | ₹8,599.50 | +1.9% | -5.0% | -5.2% | 75 | 58.2 | 0.24% | ₹1.24L Cr |
| ZYDUSLIFEZydus Lifesciences | Pharmaceuticals | Stage 2, wk 22 | ₹1,188.10 | -4.2% | +5.1% | -4.6% | 80 | 28.2 | 0.08% | ₹1.19L Cr |
| DRREDDYDr Reddy's Laboratories | Pharmaceuticals | Stage 1, wk 3 | ₹1,374.00 | +0.4% | +17.2% | -0.1% | 73 | 40.0 | 0.58% | ₹1.14L Cr |
| CIPLACipla | Pharmaceuticals | Stage 3, wk 7 | ₹1,402.00 | +0.4% | -4.0% | -11.3% | 56 | 39.0 | 0.93% | ₹1.13L Cr |
| MANKINDMankind Pharma | Pharmaceuticals | Stage 3, wk 8 | ₹2,537.90 | +2.5% | +4.1% | -3.1% | 72 | 46.2 | — | ₹1.05L Cr |
| AUROPHARMAAurobindo Pharma | Pharmaceuticals | Stage 2, wk 33 | ₹1,705.00 | +0.6% | +7.5% | -1.7% | 91 | 26.5 | — | ₹98,102 Cr |
| LUPINLupin | Pharmaceuticals | Stage 4, wk 6 | ₹2,008.60 | -0.4% | -16.7% | -20.1% | 71 | 17.0 | 0.88% | ₹91,851 Cr |
| MAXHEALTHMax Healthcare Institute | Hospitals & Diagnostic Centres | Stage 4, wk 5 | ₹927.15 | +3.5% | -13.9% | -22.1% | 41 | 65.2 | 0.22% | ₹90,242 Cr |
| MANIPALHOSManipal Health Enterprises | Hospitals & Diagnostic Centres | — | ₹667.20 | +3.9% | — | — | — | 135.8 | — | ₹87,762 Cr |
| GLENMARKGlenmark Pharmaceuticals | Pharmaceuticals | Stage 2, wk 10 | ₹2,504.70 | +4.0% | +12.6% | -0.4% | 87 | 37.8 | 0.10% | ₹70,689 Cr |
| ASTERDMAster DM Healthcare | Hospitals & Diagnostic Centres | Stage 3, wk 7 | ₹719.55 | +5.6% | -13.8% | -17.3% | 71 | 110.4 | 0.44% | ₹62,649 Cr |
| ALKEMAlkem Laboratories | Pharmaceuticals | Stage 4, wk 8 | ₹5,216.50 | -0.4% | -7.0% | -10.7% | 65 | 29.0 | 1.01% | ₹62,371 Cr |
| FORTISFortis Healthcare | Hospitals & Diagnostic Centres | Stage 4, wk 5 | ₹790.65 | +0.6% | -15.2% | -25.1% | 36 | 56.6 | 0.13% | ₹59,691 Cr |
| ABBOTINDIAAbbott India | Pharmaceuticals | Stage 4, wk 4 | ₹27,120.00 | +5.1% | -2.5% | -8.1% | 61 | 34.0 | 2.54% | ₹57,628 Cr |
| BIOCONBiocon | Biotechnology | Stage 4, wk 3 | ₹344.45 | +0.4% | -18.4% | -21.8% | 62 | 101.5 | 0.15% | ₹56,412 Cr |
| GLANDGland Pharma | Pharmaceuticals | Stage 2, wk 23 | ₹3,159.00 | 0.0% | +22.3% | 0.0% | 93 | 46.1 | 0.63% | ₹52,127 Cr |
| ANTHEMAnthem Biosciences | Biotechnology | Stage 2, wk 24 | ₹888.30 | +4.0% | +8.4% | -7.3% | 82 | 84.2 | 0.23% | ₹50,058 Cr |
| IPCALABIPCA Laboratories | Pharmaceuticals | Stage 2, wk 43 | ₹1,972.00 | +1.1% | +16.4% | -1.9% | 90 | 38.2 | 0.30% | ₹50,030 Cr |
| GLAXOGlaxoSmithKline Pharmaceuticals | Pharmaceuticals | Stage 3, wk 1 | ₹2,531.80 | -1.7% | -4.4% | -18.5% | 63 | 40.8 | 2.21% | ₹42,890 Cr |
| AJANTPHARMAjanta Pharma | Pharmaceuticals | Stage 3, wk 2 | ₹3,316.70 | -0.1% | -5.9% | -10.8% | 87 | 32.9 | 1.81% | ₹41,445 Cr |
| EMCUREEmcure Pharmaceuticals | Pharmaceuticals | Stage 3, wk 2 | ₹2,160.40 | +9.3% | +9.2% | 0.0% | 92 | 37.0 | 0.18% | ₹40,985 Cr |
| NHNarayana Hrudayalaya | Hospitals & Diagnostic Centres | Stage 4, wk 4 | ₹1,931.50 | +3.3% | +0.6% | -7.2% | 75 | 45.1 | 0.23% | ₹39,229 Cr |
| MEDANTAGlobal Health | Hospitals & Diagnostic Centres | Stage 3, wk 3 | ₹1,402.00 | +5.7% | -2.3% | -7.1% | 71 | 67.7 | 0.04% | ₹37,651 Cr |
| LALPATHLABDr. Lal PathLabs | Hospitals & Diagnostic Centres | Stage 2, wk 21 | ₹2,029.40 | +5.4% | +7.4% | 0.0% | 85 | 59.0 | 0.84% | ₹33,934 Cr |
| SAILIFESai Life Sciences | Biotechnology | Stage 2, wk 36 | ₹1,546.10 | -0.8% | +13.2% | -7.7% | 93 | 90.2 | — | ₹32,850 Cr |
| PPLPHARMAPiramal Pharma | Pharmaceuticals | Stage 2, wk 16 | ₹237.76 | +1.7% | +17.4% | -0.9% | 79 | — | — | ₹31,529 Cr |
| KIMSKrishna Institute of Medical Sciences | Hospitals & Diagnostic Centres | Stage 3, wk 8 | ₹740.55 | +1.4% | -7.0% | -12.9% | 70 | 144.1 | — | ₹31,104 Cr |
| ACUTAASAcutaas Chemicals | Biotechnology | Stage 2, wk 1 | ₹3,777.30 | -3.2% | +17.2% | -5.7% | 96 | 73.1 | 0.06% | ₹30,925 Cr |
| WOCKPHARMAWockhardt | Pharmaceuticals | Stage 2, wk 8 | ₹1,899.00 | +1.7% | -6.1% | -18.5% | 89 | 76.1 | — | ₹30,861 Cr |
| IKSInventurus Knowledge Solutions | Health Care Equipment & Supplies | Stage 3, wk 6 | ₹1,750.40 | +1.2% | -5.2% | -9.7% | 77 | 38.6 | — | ₹29,364 Cr |
| RUBICONRubicon Research | Pharmaceuticals | Stage 3, wk 1 | ₹1,716.80 | -0.1% | +13.2% | -7.7% | 98 | 98.5 | 0.09% | ₹28,420 Cr |
| NEULANDLABNeuland Laboratories | Pharmaceuticals | Stage 3, wk 1 | ₹19,576.00 | +0.8% | +1.6% | -18.4% | 82 | 50.3 | 0.17% | ₹25,116 Cr |
| GRANULESGranules India | Pharmaceuticals | Stage 3, wk 4 | ₹794.60 | -0.4% | -3.8% | -12.6% | 87 | 27.7 | 0.22% | ₹21,675 Cr |
| ALIVUSAlivus Life Sciences | Pharmaceuticals | Stage 2, wk 29 | ₹1,520.70 | +2.7% | +13.8% | 0.0% | 93 | 27.2 | 0.34% | ₹18,700 Cr |
| CAPLIPOINTCaplin Point Laboratories | Pharmaceuticals | Stage 3, wk 2 | ₹2,416.10 | +2.2% | -6.1% | -15.7% | 80 | 27.1 | 0.34% | ₹18,365 Cr |
| SHILPAMEDShilpa Medicare | Pharmaceuticals | Stage 2, wk 26 | ₹931.10 | -0.1% | +44.4% | -13.3% | 97 | 64.1 | 0.07% | ₹18,211 Cr |
| ONESOURCEOnesource Specialty Pharma | Biotechnology | Stage 4, wk 5 | ₹1,583.60 | +0.9% | +3.5% | -15.7% | 52 | — | — | ₹18,160 Cr |
| APLLTDAlembic Pharmaceuticals | Pharmaceuticals | Stage 3, wk 2 | ₹906.70 | +12.9% | +12.0% | -5.6% | 68 | 22.8 | 1.49% | ₹17,822 Cr |
| PFIZERPfizer | Pharmaceuticals | Stage 4, wk 7 | ₹3,834.70 | +0.3% | -21.1% | -27.9% | 33 | 24.2 | 1.93% | ₹17,543 Cr |
| COHANCECohance Lifesciences | Pharmaceuticals | Stage 2, wk 11 | ₹450.45 | +2.3% | +6.0% | -42.7% | 9 | 161.3 | — | ₹17,234 Cr |
| ERISEris Lifesciences | Pharmaceuticals | Stage 4, wk 10 | ₹1,215.00 | +3.2% | -11.5% | -28.6% | 36 | 22.9 | 0.61% | ₹16,857 Cr |
| SYNGENESyngene International | Labs & Life Sciences Services | Stage 4, wk 15 | ₹417.50 | +2.7% | +1.8% | -37.1% | 20 | 89.0 | 0.30% | ₹16,780 Cr |
| AGARWALEYEDr. Agarwal's Health Care | Hospitals & Diagnostic Centres | Stage 3, wk 3 | ₹523.50 | +2.1% | +6.1% | -6.6% | 69 | 110.3 | — | ₹16,597 Cr |
| POLYMEDPoly Medicure | Health Care Equipment & Supplies | Stage 3, wk 3 | ₹1,586.80 | +6.1% | -8.0% | -23.1% | 48 | 48.6 | 0.23% | ₹16,084 Cr |
| MOLBIOMolbio Diagnostics | Health Care Equipment & Supplies | — | ₹1,381.80 | +2.3% | — | — | — | 94.1 | — | ₹15,924 Cr |
| ASTRAZENAstrazeneca Pharma India | Pharmaceuticals | Stage 4, wk 15 | ₹6,368.00 | +0.4% | -22.4% | -35.2% | 27 | 93.5 | 0.57% | ₹15,920 Cr |
| NATCOPHARMNatco Pharma | Pharmaceuticals | Stage 4, wk 13 | ₹788.75 | +0.9% | -14.0% | -34.6% | 64 | 12.5 | 0.56% | ₹15,473 Cr |
| JUBLPHARMAJubilant Pharmova | Pharmaceuticals | Stage 2, wk 5 | ₹939.55 | +0.1% | +0.7% | -20.5% | 49 | 42.5 | 0.53% | ₹14,883 Cr |
| VIJAYAVijaya Diagnostic Centre | Hospitals & Diagnostic Centres | Stage 2, wk 25 | ₹1,424.60 | -1.6% | +2.9% | -9.3% | 88 | 78.1 | 0.14% | ₹14,673 Cr |
| MARKSANSMarksans Pharma | Pharmaceuticals | Stage 2, wk 24 | ₹301.65 | -4.3% | +12.1% | -13.2% | 92 | 27.9 | 0.28% | ₹13,670 Cr |
| RAINBOWRainbow Children's Medicare | Hospitals & Diagnostic Centres | Stage 3, wk 5 | ₹1,279.60 | +2.7% | -19.0% | -20.0% | 61 | 44.3 | 0.27% | ₹12,945 Cr |
| SUDEEPPHRMSudeep Pharma | Pharmaceuticals | Stage 2, wk 7 | ₹1,116.70 | +1.6% | +28.1% | — | — | 65.5 | 0.14% | ₹12,613 Cr |
| METROPOLISMetropolis Healthcare | Hospitals & Diagnostic Centres | Stage 3, wk 4 | ₹581.25 | +2.2% | -0.6% | -3.5% | 80 | 56.7 | 0.36% | ₹12,059 Cr |
| AKUMSAkums Drugs and Pharmaceuticals | Pharmaceuticals | Stage 2, wk 29 | ₹751.50 | -1.3% | +12.6% | -8.7% | 92 | 32.0 | 0.39% | ₹11,506 Cr |
| VIYASHViyash Scientific | Pharmaceuticals | — | ₹228.46 | +4.1% | -14.2% | — | — | 55.0 | — | ₹10,083 Cr |
| PARKHOSPSPark Medi World | Hospitals & Diagnostic Centres | Stage 3, wk 4 | ₹230.45 | +3.0% | -18.8% | — | — | 35.1 | — | ₹9,954 Cr |
| YATHARTHYatharth Hospital & Trauma Care Services | Hospitals & Diagnostic Centres | Stage 2, wk 26 | ₹1,027.90 | +4.7% | +21.6% | -11.6% | 84 | 54.7 | 0.05% | ₹9,904 Cr |
| PGHLProcter & Gamble Health | Pharmaceuticals | Stage 4, wk 3 | ₹5,738.00 | -2.1% | -11.5% | -17.1% | 63 | 27.7 | 3.53% | ₹9,525 Cr |
| STARStrides Pharma Science | Pharmaceuticals | Stage 2, wk 6 | ₹1,014.20 | -2.2% | +2.0% | -17.7% | 82 | 15.4 | 0.49% | ₹9,348 Cr |
| HCGHealthcare Global Enterprises | Hospitals & Diagnostic Centres | Stage 3, wk 3 | ₹621.35 | +1.6% | -7.6% | -20.0% | 51 | 395.1 | — | ₹9,277 Cr |
| BLUEJETBlue Jet Healthcare | Pharmaceuticals | Stage 3, wk 5 | ₹531.85 | +7.1% | -8.6% | -21.1% | 48 | 36.6 | 0.24% | ₹9,226 Cr |
| JLHLJupiter Life Line Hospitals | Hospitals & Diagnostic Centres | Stage 4, wk 1 | ₹279.55 | +6.3% | -13.1% | -15.9% | 56 | 48.3 | 0.08% | ₹9,164 Cr |
| AARTIPHARMAarti Pharmalabs | Labs & Life Sciences Services | Stage 2, wk 11 | ₹926.50 | +0.7% | +34.3% | -5.0% | 77 | 32.5 | 0.38% | ₹8,401 Cr |
| SANOFICONRSanofi Consumer Healthcare India | Pharmaceuticals | Stage 4, wk 9 | ₹3,472.60 | -0.7% | -23.3% | -30.9% | 36 | 28.6 | 2.16% | ₹8,009 Cr |
| SANOFISanofi India | Pharmaceuticals | Stage 4, wk 8 | ₹3,450.80 | +2.0% | +1.7% | -27.1% | 35 | 21.4 | 3.63% | ₹7,947 Cr |
| THYROCAREThyrocare Technologies | Hospitals & Diagnostic Centres | Stage 3, wk 4 | ₹495.50 | +2.6% | -18.1% | -23.7% | 77 | 53.8 | 1.43% | ₹7,887 Cr |
| SUVENSuven Life Sciences | Pharmaceuticals | Stage 3, wk 4 | ₹276.10 | +5.7% | -10.9% | -29.6% | 88 | — | — | ₹7,802 Cr |
| ENTEROEntero Healthcare Solutions | Pharmaceuticals | Stage 2, wk 12 | ₹1,665.00 | +5.3% | +35.2% | -12.3% | 90 | 54.9 | — | ₹7,254 Cr |
| SUPRIYASupriya Lifescience | Pharmaceuticals | Stage 2, wk 5 | ₹859.90 | +3.3% | -3.1% | -18.3% | 78 | 34.5 | 0.12% | ₹6,921 Cr |
| CONCORDBIOConcord Biotech | Pharmaceuticals | Stage 3, wk 2 | ₹655.50 | +6.8% | -7.7% | -17.4% | 60 | 46.0 | 0.61% | ₹6,858 Cr |
| BLISSGVSBliss GVS Pharma | Pharmaceuticals | Stage 2, wk 48 | ₹619.55 | -1.9% | +26.5% | -16.0% | 99 | 42.5 | 0.24% | ₹6,591 Cr |
| KOVAIKovai Medical Center & Hospital | Hospitals & Diagnostic Centres | — | ₹5,995.00 | +1.8% | — | — | — | 25.6 | 0.25% | ₹6,560 Cr |
| FDCF D C | Pharmaceuticals | Stage 4, wk 8 | ₹390.95 | +0.6% | -2.9% | -14.0% | 59 | 20.2 | 1.29% | ₹6,365 Cr |
| NEPHROPLUSNephrocare Health Services | Hospitals & Diagnostic Centres | Stage 3, wk 3 | ₹622.35 | -0.4% | -12.7% | — | — | 69.8 | — | ₹6,258 Cr |
| SPARCSun Pharma Advanced Research Co | Pharmaceuticals | Stage 3, wk 10 | ₹185.33 | +5.5% | -10.6% | -33.2% | 84 | 3.6 | — | ₹6,014 Cr |
| INNOVACAPInnova Captab | Pharmaceuticals | Stage 2, wk 22 | ₹1,035.00 | +3.2% | +9.9% | -20.2% | 83 | 37.0 | 0.20% | ₹5,923 Cr |
| MOREPENLABMorepen Laboratories | Pharmaceuticals | Stage 2, wk 20 | ₹101.33 | -1.0% | +46.5% | -31.1% | 96 | 28.3 | 0.21% | ₹5,552 Cr |
| SENORESSenores Pharmaceuticals | Pharmaceuticals | Stage 3, wk 4 | ₹1,137.00 | -0.9% | -16.4% | -26.7% | 89 | 37.5 | — | ₹5,236 Cr |
| GUJTHEMGujarat Themis Biosyn | Pharmaceuticals | Stage 2, wk 8 | ₹387.75 | +2.8% | +9.6% | -17.0% | 50 | 84.3 | 0.18% | ₹5,047 Cr |
| SMTSahajanand Medical Technologies | Health Care Equipment & Supplies | — | ₹485.90 | +6.0% | — | — | — | 67.3 | — | ₹4,939 Cr |
| SMSPHARMASMS Pharmaceuticals | Pharmaceuticals | Stage 2, wk 6 | ₹525.50 | +2.2% | +44.6% | 0.0% | 94 | 44.8 | 0.08% | ₹4,921 Cr |
| ORCHPHARMAOrchid Pharma | Pharmaceuticals | Stage 3, wk 3 | ₹876.75 | +4.0% | -12.9% | -20.8% | 82 | 532.8 | — | ₹4,447 Cr |
| GUFICBIOGufic Biosciences | Pharmaceuticals | Stage 2, wk 18 | ₹428.90 | +3.0% | +8.0% | -4.3% | 83 | 56.7 | 0.02% | ₹4,301 Cr |
| RPGLIFERPG Life Sciences | Pharmaceuticals | Stage 2, wk 19 | ₹2,598.50 | +2.7% | -5.4% | -15.9% | 75 | 38.1 | 0.93% | ₹4,298 Cr |
| ZOTAZota Health Care | Pharmaceuticals | Stage 1, wk 3 | ₹1,217.90 | -1.2% | -2.8% | -27.8% | 40 | — | 0.08% | ₹4,218 Cr |
| JSLLJeena Sikho Lifecare | Pharmaceuticals | Stage 4, wk 19 | ₹336.65 | -2.1% | -41.4% | -57.6% | 5 | 18.0 | 1.31% | ₹4,185 Cr |
| AARTIDRUGSAarti Drugs | Pharmaceuticals | Stage 3, wk 2 | ₹455.80 | -2.3% | +10.1% | -12.0% | 61 | 22.3 | 0.43% | ₹4,160 Cr |
| KPLKwality Pharmaceuticals | Pharmaceuticals | Stage 2, wk 43 | ₹3,741.00 | +3.0% | +44.6% | -2.6% | 99 | 46.1 | — | ₹3,882 Cr |
| UNICHEMLABUnichem Laboratories | Pharmaceuticals | Stage 3, wk 4 | ₹505.45 | +0.4% | +1.0% | -22.3% | 74 | 12.0 | — | ₹3,559 Cr |
| SHUKRAPHARShukra Pharmaceuticals | Pharmaceuticals | — | ₹79.87 | 0.0% | — | — | — | 103.4 | 0.01% | ₹3,534 Cr |
| INDSWFTLABIND Swift Laboratories | Pharmaceuticals | Stage 2, wk 21 | ₹370.55 | +7.8% | +61.0% | -10.3% | 99 | 36.7 | — | ₹3,274 Cr |
| SOLARASolara Active Pharma Sciences | Pharmaceuticals | Stage 2, wk 9 | ₹644.90 | +2.4% | +23.9% | -14.3% | 75 | 82.2 | — | ₹3,112 Cr |
| INDRAMEDCOIndraprastha Medical Corporation | Hospitals & Diagnostic Centres | Stage 4, wk 24 | ₹336.30 | +5.6% | -9.2% | -46.0% | 15 | 15.7 | 1.24% | ₹3,083 Cr |
| HIKALHikal | Pharmaceuticals | Stage 3, wk 4 | ₹222.63 | +3.8% | -2.6% | -13.0% | 60 | — | 0.28% | ₹2,745 Cr |
| DRAGARWQDr Agarwals Eye Hospital | Hospitals & Diagnostic Centres | Stage 2, wk 11 | ₹5,423.00 | +2.9% | +6.7% | -5.8% | 72 | 33.2 | 0.08% | ₹2,621 Cr |
| FREDUNFredun Pharmaceuticals | Pharmaceuticals | Stage 2, wk 31 | ₹1,508.70 | +3.7% | +35.9% | -2.8% | 98 | 52.8 | — | ₹2,577 Cr |
And 77 more. See all of them in the screener →
Healthcare Stocks: quick answers
How many healthcare stocks are in an uptrend?
As of 4 Nov 2026, 66 of the 177 NSE-listed healthcare stocks we track are in Stage 2, the uptrend phase, including Divi's Laboratories (DIVISLAB), Laurus Labs (LAURUSLABS), Zydus Lifesciences (ZYDUSLIFE), Aurobindo Pharma (AUROPHARMA) and Glenmark Pharmaceuticals (GLENMARK).
What is the largest healthcare stock?
Sun Pharmaceutical Industries (SUNPHARMA), with a market value of ₹4.25L Cr. It closed at ₹1,773.40 on 4 Nov 2026, in Stage 3.
Which healthcare stocks are near their 52-week high?
As of 4 Nov 2026, 6 are within 5% of a 52-week high: Divi's Laboratories (DIVISLAB), Laurus Labs (LAURUSLABS), Zydus Lifesciences (ZYDUSLIFE), Dr Reddy's Laboratories (DRREDDY), Mankind Pharma (MANKIND) and Aurobindo Pharma (AUROPHARMA).